Trial Profile
A retrospective cohort study to evaluate the factors influencing treatment duration in metastatic colorectic cancer patients treated with Ziv-Aflibercept
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Nov 2015
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colon cancer
- Focus Therapeutic Use
- 19 Nov 2015 New trial record
- 11 Nov 2015 Results presented at the 18th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research